文献速递心脑血管急症消化、代谢与肾脏急症

6国低收入与高收入急性心肌梗死患者治疗模式与结局差异

Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries.
PubMed 文献 · JAMA · 2023-01-01
一句话结论在6个高收入国家,高收入AMI患者30天及1年死亡率更低、血运重建更多、住院更短、再入院更少,差异在全民医保国家同样存在。

该序列横断面队列研究纳入2013至2018年美国、加拿大、英格兰、荷兰、中国台湾和以色列年龄≥66岁因急性心肌梗死住院的全部成人,按收入五分位比较治疗与结局。高收入患者调整后30天死亡率一般低1至3个百分点,STEMI的1年死亡率差异更大(以色列16.2% vs 25.3%,差异-9.1个百分点[95%CI,-16.7至-1.6])。几乎所有国家高收入人群心导管检查和经皮冠状动脉介入率更高(绝对差1至6个百分点),30天再入院率低1至3个百分点、住院时间短0.2至0.5天。作者认为,即使在有全民医保和健全社会保障体系的国家,也存在基于收入的差异。

要点

  • 高收入AMI患者调整后30天死亡率一般比低收入者低1至3个百分点(如荷兰STEMI 10.2% vs 13.1%,差异-2.8个百分点[95%CI,-4.1至-1.5])。
  • STEMI的1年死亡率差异大于30天,以色列差异最大(高收入16.2% vs 低收入25.3%,差异-9.1个百分点[95%CI,-16.7至-1.6])。
  • 所有国家高收入者心导管检查和PCI率更高,绝对差1至6个百分点(英格兰STEMI PCI 73.6% vs 67.4%,差异6.1个百分点[95%CI,1.2至11.0])。
  • 高收入者30天再入院率一般低1至3个百分点,住院时间一般短0.2至0.5天。
  • STEMI的CABG率在低收入与高收入层相似,但NSTEMI高收入者一般高1至2个百分点(美国12.5% vs 11.0%,差异1.5个百分点[95%CI,1.3至1.8])。

适用人群与场景

  • 2013至2018年在美国、加拿大、英格兰、荷兰、中国台湾和以色列因急性心肌梗死住院的年龄≥66岁成人,数据来自具有人群代表性的行政数据。
  • 纳入STEMI患者289 376例和NSTEMI患者843 046例。
  • 暴露为各国内部和跨国比较的收入最高五分位与最低五分位。

研究设计与关键结果

  • 研究设计为序列横断面队列研究,纳入6个国家2013至2018年年龄≥66岁的急性心肌梗死住院患者,比较收入最高与最低五分位人群。
  • 调整后30天死亡率一般高收入者低1至3个百分点;荷兰STEMI高收入10.2% vs 低收入13.1%,差异-2.8个百分点(95%CI,-4.1至-1.5)。
  • STEMI的1年死亡率差异大于30天死亡率,以色列差异最大:高收入16.2% vs 低收入25.3%,差异-9.1个百分点(95%CI,-16.7至-1.6)。
  • 所有国家高收入者心导管检查和PCI率更高,绝对差1至6个百分点;英格兰STEMI的PCI高收入73.6% vs 低收入67.4%,差异6.1个百分点(95%CI,1.2至11.0)。
  • STEMI的CABG率在低收入与高收入层相似,NSTEMI高收入者一般高1至2个百分点;美国NSTEMI高收入12.5% vs 低收入11.0%,差异1.5个百分点(95%CI,1.3至1.8)。
  • 高收入者30天再入院率一般低1至3个百分点,住院时间一般短0.2至0.5天。

证据类型、等级与局限

  • 证据类型:序列横断面队列研究,使用具有人群代表性的行政数据。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,研究结果提示即使存在全民健康保险和健全的社会安全网体系,基于收入的差异依然存在。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Differences in the organization and financing of health systems may produce more or less equitable outcomes for advantaged vs disadvantaged populations. We compared treatments and outcomes of older high- and low-income patients across 6 countries.

OBJECTIVE: To determine whether treatment patterns and outcomes for patients presenting with acute myocardial infarction differ for low- vs high-income individuals across 6 countries.

DESIGN, SETTING, AND PARTICIPANTS: Serial cross-sectional cohort study of all adults aged 66 years or older hospitalized with acute myocardial infarction from 2013 through 2018 in the US, Canada, England, the Netherlands, Taiwan, and Israel using population-representative administrative data.

EXPOSURES: Being in the top and bottom quintile of income within and across countries.

MAIN OUTCOMES AND MEASURES: Thirty-day and 1-year mortality; secondary outcomes included rates of cardiac catheterization and revascularization, length of stay, and readmission rates.

RESULTS: We studied 289 376 patients hospitalized with ST-segment elevation myocardial infarction (STEMI) and 843 046 hospitalized with non-STEMI (NSTEMI). Adjusted 30-day mortality generally was 1 to 3 percentage points lower for high-income patients. For instance, 30-day mortality among patients admitted with STEMI in the Netherlands was 10.2% for those with high income vs 13.1% for those with low income (difference, -2.8 percentage points [95% CI, -4.1 to -1.5]). One-year mortality differences for STEMI were even larger than 30-day mortality, with the highest difference in Israel (16.2% vs 25.3%; difference, -9.1 percentage points [95% CI, -16.7 to -1.6]). In all countries, rates of cardiac catheterization and percutaneous coronary intervention were higher among high- vs low-income populations, with absolute differences ranging from 1 to 6 percentage points (eg, 73.6% vs 67.4%; difference, 6.1 percentage points [95% CI, 1.2 to 11.0] for percutaneous intervention in England for STEMI). Rates of coronary artery bypass graft surgery for patients with STEMI in low- vs high-income strata were similar but for NSTEMI were generally 1 to 2 percentage points higher among high-income patients (eg, 12.5% vs 11.0% in the US; difference, 1.5 percentage points [95% CI, 1.3 to 1.8 ]). Thirty-day readmission rates generally also were 1 to 3 percentage points lower and hospital length of stay generally was 0.2 to 0.5 days shorter for high-income patients.

CONCLUSIONS AND RELEVANCE: High-income individuals had substantially better survival and were more likely to receive lifesaving revascularization and had shorter hospital lengths of stay and fewer readmissions across almost all countries. Our results suggest that income-based disparities were present even in countries with universal health insurance and robust social safety net systems.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Landon BE, Hatfield LA, Bakx P, et al. Differences in Treatment Patterns and Outcomes of Acute Myocardial Infarction for Low- and High-Income Patients in 6 Countries. JAMA. 2023. PMID: 37014339. doi:10.1001/jama.2023.1699

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。